Brii Biosciences Limited
BRIBF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$74,034 | -$231,846 | -$280,535 | $15,088 |
| Dep. & Amort. | $0 | $2,808 | $6,042 | $7,159 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,131 | $12,912 | $3,139 | $31,382 |
| Change in WC | $0 | -$50,409 | $0 | -$33,144 |
| Other Non-Cash | $72,903 | $192,984 | $158,460 | -$140,612 |
| Operating Cash Flow | $0 | -$147,102 | -$225,788 | -$240,253 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$2,463 | -$765 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$1,943,360 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $2,848,092 | $0 | $0 |
| Other Inv. Act. | $0 | -$400,707 | $197,719 | $124,530 |
| Investing Cash Flow | $0 | $501,562 | $196,954 | $124,530 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $53 | $0 | $0 |
| Stock Repurch. | $0 | -$220 | $0 | -$1,162 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$2,325 | -$2,211 | -$1,936 |
| Financing Cash Flow | $0 | -$2,492 | -$2,211 | -$3,098 |
| Forex Effect | $0 | -$1,184 | $1,454 | -$228 |
| Net Chg. in Cash | $0 | $920,062 | $83,303 | $1,078 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $0 | $83,303 | $0 | $0 |
| End Cash | $0 | $1,003,365 | $83,303 | $1,078 |
| Free Cash Flow | $0 | -$149,565 | -$226,553 | -$240,253 |